すべての画像(2)
About This Item
実験式（ヒル表記法）:
Y
CAS番号:
分子量:
88.91
MDL番号:
UNSPSCコード:
12141617
PubChem Substance ID:
NACRES:
NA.23
おすすめの製品
詳細
For updated SDS information please visit www.goodfellow.com.
法的情報
Goodfellow製品
保管分類コード
13 - Non Combustible Solids
WGK
WGK 3
引火点(°F)
Not applicable
引火点(℃)
Not applicable
試験成績書（COA）
製品のロット番号・バッチ番号を入力して、試験成績書（COA） を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
Aki Aoyama et al.
Molecular cancer therapeutics, 13(12), 2978-2990 (2014-10-15)
Tivantinib (ARQ197) was first reported as a highly selective inhibitor of c-MET and is currently being investigated in a phase III clinical trial. However, as recently reported by us and another group, tivantinib showed cytotoxic activity independent of cellular c-MET
Xue Wang et al.
Journal of nanoscience and nanotechnology, 14(5), 3910-3913 (2014-04-17)
Nd3+ doped alpha-NaYF4 nanocrystals with size of about 15 nm were successfully synthesized through hydrothermal method. Nearly pure near-infrared to near-infrared (NIR-to-NIR) luminescence can be realized. Moreover, the excitation and the emission at 880 and 1060 nm, respectively, are away
Yukiko Ishihara et al.
Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, 31(8), 781-785 (2015-08-11)
With a view to enhance the sensitivity of analytical instruments used in the measurement of trace elements contained in a single cell, we have now equipped the previously reported micro-droplet injection system (M-DIS) with a desolvation system. This modified M-DIS
G Scholz et al.
Dalton transactions (Cambridge, England : 2003), 44(30), 13522-13529 (2015-07-03)
Nanoscopic yttrium acetate fluorides Y(CH(3)COO)(3-z)F(z) and yttrium oxide fluorides YO(3-z)/(2)F(z )were prepared with tunable Y/F molar ratios via the fluorolytic sol-gel route. All samples were characterized by X-ray diffraction, elemental analysis and thermal analysis. In addition, local structures of all
Ryan Hickey et al.
International journal of radiation oncology, biology, physics, 88(5), 1025-1031 (2014-03-26)
Radiosensitizing chemotherapy improves the outcomes in comparison with radiation alone for gastrointestinal cancers. The delivery of radiation therapy with yttrium90 ((90)Y) radioembolization, in combination with the radiosensitizing chemotherapeutic agent capecitabine, provides the opportunity to enhance the effects of radiation on
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）